Cargando…
Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein
Eltrombopag is a small molecule TPO-R agonist that has been shown in our previous studies to inhibit tumor growth by targeting Human antigen R (HuR) protein. HuR protein not only regulates the mRNA stability of tumor growth-related genes, but it also regulates the mRNA stability of a variety of canc...
Autores principales: | Chen, Yao, Zhang, Rui, Yang, Liuqing, Zhang, Pei, Wang, Feiyun, Lin, Guoqiang, Zhang, Jiange, Zhu, Yuying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963984/ https://www.ncbi.nlm.nih.gov/pubmed/36834574 http://dx.doi.org/10.3390/ijms24043164 |
Ejemplares similares
-
Discovery of the anti-angiogenesis effect of eltrombopag in breast cancer through targeting of HuR protein
por: Zhu, Yuying, et al.
Publicado: (2020) -
Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence
por: Yi, Jie, et al.
Publicado: (2010) -
Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation
por: Yang, Feng, et al.
Publicado: (2019) -
The fungal natural product azaphilone-9 binds to HuR and inhibits HuR-RNA interaction in vitro
por: Kaur, Kawaljit, et al.
Publicado: (2017) -
Correction: Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation
por: Yang, Feng, et al.
Publicado: (2023)